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In the present study, aqueous extract of Moringa oleifera was  evaluated for its 
antiurolithiatic potential in albino rats of Wistar strain. The vesical calculi were 
produced by zinc disc  insertion into the urinary bladder of rats supplemented with 
1%ethylene glycol in drinking water. The drug / extract was administered orally 
daily in two doses (400mg and 800mg/kg) for four to eight weeks in different 
groups of animals [Prophylactic and Curative].The reduction in weight of the 
vesical calculi was used as criteria for assessing the prophylactic or curative 
antiurolithiatic effect of the pods of this plant. In both the groups the administration 
of the aqueous extract of Moringa oleifera pods [AEMO] has resulted in significant 
reduction in the weight of calculi as compared to the control group. It can be 
concluded that pods of Moringa oleifera has antiurolithiatic activity.  
Keywords:   Moringa oleifera,  antiurolithiatic activity, zinc disc. 
 
Introduction 
Moringa oleifera is an important medicinal herb, belonging to the family Moringaceae. It is 
considered as miracle tree as all the parts of the plant are said to have medicinal prperties. It is also 
known as drum stick tree, horseradish tree, clarifier tree and mother’s best friend in different parts 
of the world, based on their appearance and unique uses. It is mostly cultivated all over the plains 









The various parts of the plant used include flower, pod, leaves, bark and roots.  The flowers, which 
must be cooked, are eaten either mixed with other foods or fried in butter and have been shown to 
be rich in potassium and calcium
4
. The leaves are eaten as greens, in salads, in vegetable curries, 
as pickles and for seasoning. The Bark is regarded as an antiscorbic, and it exudes a reddish gum 
sometimes used for the treatment of diarrhoea. The roots are bitter, act as a tonic to the body and 
lungs, and have an expectorant activity. They are a mildly diuretic and are used as a stimulant in 
paralytic afflictions, epilepsy and hysteria.  The pods are the most valued and widely used of all 
the tree parts. The pods are extremely nutritious, containing all the essential amino acids along 
with many vitamins and other nutrients. The immature pod can be eaten raw or prepared like green 
peas or green beans, while the mature pods are usually fried and possess a peanut-like flavour. The 
pods also yield 38 - 40% of non-drying, edible oil known as Ben Oil which is clear, sweet and 




In recent decades, many scientific studies using the extracts of leaves, pods and roots of Moringa 
















, and analgesic activity
14
 . 
 Even though the root extracts of Moringa oleifera have been studied for diuretic activity 
11
, there 
is no scientific study showing diuretic and antiurolithiatic  activity of Moringa oleifera pod extract. 
Therefore this study was conducted in order to evaluate its antiurolithiatic activity in rats.                                     
Materials and Methods 
Approval for the project: Approval for the experiment was obtained from the Institutional animal 
ethics committee (IAEC), Kasturba Medical College, Manipal, vide letter No. IAEC/KMC 
07/2008-2009. 
 
Plant material: The pods of Moringa oleifera Lam. Available locally were collected between 
February and May in and around Udupi. The botanical identity has been confirmed by department 
of botany, Sri Poornapagna College, Udupi.  The voucher specimen is preserved in the laboratory 
for future reference. 
 
Method of extraction: The fresh pods were cut into small pieces, partially crushed and soaked in 
water overnight which was later subjected to boiling for 6 hours. The resultant extract was then 
drained and concentrated in a water bath to get the concentrated extract. The yield of the extract 
was 8.5%.  The extract was stored in desiccators and used for further experiments after dissolving 
it in distilled water.  
 Animals: Inbred albino rats of Wistar strain, of either sex, aged around 2 to 3 months and 
weighing 150 – 200g were used. They were housed in standard conditions of temperature 
(25±2°C), relative humidity of 45-55%, and maintained on 12-hour light: 12-hour dark cycle in 
animal house of Kasturba Medical College, Manipal. They were fed standard pellet diet 
(Hindustan Lever rat pellets) and water ad libitum. 
Acute toxicity study: The aqueous extract of Moringa oleifera pod was administered orally in the 
escalating dosages, up to 8g/kg to different groups of rats (n=6). The animals were observed for 
behavioural and physiological variations initially continuously for 4 hours, followed by  4
th
 hourly 
for 12 hours and there after once daily for 14 days.  





Antiurolithiatic study : Method of induction of urolithiasis by insertion of zinc disc 
15-19
. Rats were 
anaesthetized with intraperitoneal ketamine(50mg/kg). A suprapubic incision was made and the 
abdomen was opened. The urinary bladder was then carefully exposed and the urine in the bladder 
was aspirated with a sterile syringe. A small nick was made at the apex end of urinary bladder and 
the sterile zinc disc (previously weighed) was carefully inserted into the bladder. Then the bladder 
was closed in a single stitch using chromic catgut (4-0). The abdomen was then closed in layers 
with chromic catgut and skin was closed with silk thread. The rats were allowed to recover from 
anaesthesia. Food and 1% ethylene glycol in water was given ad libitum. The stone was allowed to 
form and grow inside the bladder during the study period. After the study period the rats were 
sacrificed and zinc disc implants/stones were removed from the bladder and dried. Stones taken 
out were weighed. The difference between initial and final weights indicated the amount of stone 
formed.  
Grouping of animals for different treatments and procedure of the study: Adult albino rats of 
Wistar strain, weighing between 150-200 g, were selected for the study. In this study the rats were 
divided into 6 groups with 6 animals in each group receiving different treatments. Group I- 
Prophylactic control(1%ethylene glycol for 4 weeks),Group II-Prophylactic treatment (1%ethylene 
glycol+AEMO 400mg/kg orally for 4 weeks), Group III -Prophylactic treatment (1%ethylene 
glycol+AEMO 800mg/kg orally for 4 weeks), Group IV-Curative control (1%ethylene glycol for 4 
weeks followed by water for 4 weeks),Group V-Curative treatment (1%ethylene glycol for 4 
weeks followed by AEMO 400mg/kg for 4 weeks), Group VI-Curative treatment (1%ethylene 
glycol for 4 weeks followed by AEMO800mg/kg for 4 weeks). Prophylactic activity against 
urolithiasis was tested in Groups I to III in this study and, after 4 weeks, animals were sacrificed 
and vesical calculi were collected, weighed and statistically evaluated. Curative property was 
tested in Groups IV to VI in the study and, at the end of eight weeks, animals were sacrificed and 
vesical calculi were collected, weighed and statistically evaluated.  
Weight of calculi: The difference between the weight of the implanted zinc discs at the time of 





  week period indicated the weight of deposited stone. 
Statistical analysis: The data obtained from the study was statistically evaluated using a parametric 
test ANOVA (Analysis of Variance) and Turkey as post hoc test. This was done with SPSS 
(Statistical package for social science) software 
Results 
 The results of different groups studied using  aqueous extract of pods of  Moringa oleifera 
400mg/kg & 800mg/kg are  shown in table 1.  In this study,  the extracts from  pods of the plant 













Table 1.  
Weight of deposits on zinc discs in various experimental groups of rats 
Groups 
[n=6 in each group] 
Weight of calculi (mg)                                                                                                         
(Mean± SEM) 
Group I - Prophylactic control 273.5 ± .10 
 
Group II -  Prophylactic 











Group IV - Curative control 256.1 ± 42.69 
 
















In the present study, aqueous extract of pods of  Moringa oleifera 400mg/kg & 800mg/ were 
evaluated for the antiurolithiatic potential in albino rats of Wistar strains.  The method used for 
induction of stones in this study was zinc disc foreign body insertion technique into the bladder of 
rats supplemented with 1% ethylene glycol in drinking water, which is commonly used in these 
type of studies. 
In this study, the weight of the stones was used as criteria for assessing the preventive or curative 
effect of the pods of Moringa oleifera. Two doses of extract for prophylactic and curative groups 
were used. In both groups the administration of the extract have resulted in significant reduction in 
the weight of stones compared to the control group. 
The decrease in the bladder stone formation was inconsistent with the increase in the dose of the 
extract which could be due to variability in the response due to physiological variation. The stone 
formation in the control group itself was variable to a certain extent ranging from 240 mg to 296 
mg in prophylactic control group and 236 mg to 296 mg in curative control group, which is 
indicative of normal physiological variation. Among the different strains of rats used for 
preclinical studies, Wistar rats are much less susceptible to persistent bladder infection and struvite 
stone formation in comparison to other strains. In a study where female Fischer 344 (F344),
 
Lewis 
(LEW), Sprague-Dawley (SD), and Wistar (WIS) rats were inoculated with
 
a host-adapted strain of 





Ureaplasma parvum, and necropsied
 
at 2 weeks post inoculation; 100% of F344, 42% of SD, 10% 
of
 
LEW, and 10% of WIS rats remained infected. Severe bladder lesions
 
and struvite calculi were 
seen in 64% of F344 rats; in other
 
rat strains, bladder lesions were mild or absent
20
. In this study 
there was no signs of infection and the weight of stones formed in the bladder were significantly 
reduced after the administration of aqueous extract of Moringa oleifera in both preventive and 
curative groups of animals. The extract is more effective in preventing the  stone formation in 
bladder of rats in our experiments.     
Conclusion 
 In conclusion we can confirm the possibility of antiurolithiatic activity of pods of  Moringa 
oleifera as there was reduction in size of the stones. Further studies are needed to prove the stone 
dissolving property of aqueous extract of pods of  Moringa oleifera (400mg/kg & 800mg/kg) in 
other animal models and also further studies are required for isolation of active ingredients 
/compounds in the extract. 
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